Nesfatin-1 neurons represent a population of hypothalamic neurons that produce the satiety peptide nesfatin-1, derived from the precursor protein nucleobindin 2 (NUCB2)[1]. These neurons play critical roles in energy homeostasis, metabolic regulation, and have emerging connections to neurodegenerative disease processes[2].
| Property | Value |
|---|---|
| Category | Neuropeptide Neurons |
| Location | Hypothalamus (PVN, LHA, ARC), NTS, medulla |
| Cell Types | NUCB2/nesfatin-1 neurons |
| Primary Neurotransmitter | Nesfatin-1 peptide |
| Key Markers | NUCB2, NESFATIN-1 |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Allen Brain Cell Atlas | Search | Nesfatin-1 Neurons |
| Cell Ontology (CL) | Search | Check classification |
| Human Cell Atlas | Search | Check expression data |
| CellxGene Census | Search | Check cell census |
Nesfatin-1 neurons are primarily located in the hypothalamic paraventricular nucleus (PVN), lateral hypothalamic area (LHA), and arcuate nucleus (ARC)[3]. These brain regions are critical for:
Beyond the hypothalamus, nesfatin-1 neurons project to:
Nesfatin-1 is a 82-amino acid peptide derived from the 420-amino acid precursor NUCB2[4]. The peptide is processed through the secretory pathway and can be detected in:
Nesfatin-1 exerts its effects through:
The specific receptor for nesfatin-1 remains incompletely characterized, though pharmacological studies suggest involvement of unknown GPCRs[5].
Nesfatin-1 neurons are central to metabolic regulation[6]:
Nesfatin-1 pathway modulation represents a potential therapeutic target for:
Recent research suggests nesfatin-1 may have neuroprotective effects[10]:
Preliminary studies suggest nesfatin-1 may interact with:
Emerging evidence links nesfatin-1 to:
Nesfatin-1 dysregulation has been implicated in several metabolic conditions:
Key questions remaining in nesfatin-1 research include:
Nesfatin-1 neurons represent an important hypothalamic cell population with diverse functions in metabolism, mood, and potentially neuroprotection. Further research into this neuronal population may yield therapeutic insights for metabolic and neurodegenerative diseases.
Foo K, et al. Nesfatin-1: Distribution and functional role in the rat brain. Neuroscience. 2008. ↩︎
Garcia-Galiano D, et al. NUCB2/nesfatin-1 and its endocrine functions. Frontiers in Endocrinology. 2012. ↩︎
Brailoiu GC, et al. Nesfatin-1: Distribution and effects in the brain. Journal of Molecular Neuroscience. 2007. ↩︎
Oh IS, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. 2006. ↩︎
Maejima Y, et al. Nesfatin-1 receptor signaling in the brain. Journal of Neuroendocrinology. 2019. ↩︎
Liu J, et al. Nesfatin-1 and energy homeostasis. Frontiers in Physiology. 2020. ↩︎
Ge JF, et al. Nesfatin-1 and mood disorders. Progress in Neuropsychopharmacology. 2014. ↩︎
Baskaran M, et al. Nesfatin-1 in depression. Journal of Affective Disorders. 2015. ↩︎
Jiang G, et al. Neuroprotective effects of nesfatin-1. Neurochemical Research. 2019. ↩︎